Wired News - K2M Announces US Launch of MOJAVE PL 3D Expandable System
Stock Monitor: Cutera Post Earnings Reporting
LONDON, UK / ACCESSWIRE / May 18, 2018 / If you want access to our free research report on K2M Group Holdings, Inc. (NASDAQ: KTWO) ("K2M"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=KTWO as the Company's latest news hit the wire. On May 16, 2018, the Company, which is a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance, declared the US commercial launch of its first-to-market MOJAVE PL 3D Expandable Interbody System. Register today and get access to over 1,000 Free Research Reports by joining our site below:
www.active-investors.com/registration-sg
Active-Investors.com is currently working on the research report for Cutera, Inc. (NASDAQ: CUTR), which also belongs to the Healthcare sector as the Company K2M Group Holdings. Do not miss out and become a member today for free to access this upcoming report at:
www.active-investors.com/registration-sg/?symbol=CUTR
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, K2M Group Holdings most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:
www.active-investors.com/registration-sg/?symbol=KTWO
Balance ACS and Total Body Balance
The Balance ACS (or BACS) technology addresses each anatomical vertebral segment with a 360-degree approach of the axial, coronal, and sagittal planes. It provides surgical solutions for achieving balance of the spine, using Total Body Balance as an important component of surgical success.
Unique Features of MOJAVE PL 3D
K2M was the first leading spine Company to sell a 3D-printed titanium interbody device. In fact, the Company offers the most comprehensive portfolio of 3D-printed spinal devices in the market.
The MOJAVE PL 3D has been developed with K2M's lamellar 3D titanium technology. It is the first-of-its-kind fusion device that permits independent control of the anterior and posterior heights in the lumbar spine. The MOJAVE PL 3D Expandable system incorporates a porous structure in combination with rough surfaces, and thus allows bony integration throughout the endplates. It offers infinite adjustment within the expansion range as it can be locked at any height and lordosis to help the restoration of sagittal balance.
K2M's lamellar 3D Titanium Technology creates structures using cutting-edge 3D printing methods, much advanced than the traditional manufacturing techniques. The MOJAVE endplates are created using high-energy laser beam, with complex internal geometries and a rough surface architecture associated with bone growth activity.
The US Food and Drug Administration (FDA) awarded MOJAVE PL 3D Expandable Interbody System a 510(k) Clearance in June 2017.
A New Improved Treatment Option for Surgeons
Michael P. Donahue, DO, Director of Spine Surgery and President at the Center for Advanced Orthopedics and Sports Medicine in Auburn Hills, Michigan, shared that developments in expandable interbody technology would give more opportunities to surgeons for treating sagittal imbalance. The MOJAVE PL 3D Expandable Interbody System leverages a breakthrough 3D-printing method to permit bony integration throughout the implant. Besides, its infinite adjustment tools enable accurate matching of the implant with the unique anatomies of patients.
Eric Major, Chairman, President, and Chief Executive Officer (CEO) of K2M, also believes that the launch of the MOJAVE PL 3D Expandable Interbody System marks a noteworthy advancement in expandable interbody technology. Its unique capabilities offer surgeons a more flexible way of facilitating 3D sagittal balance in their patients. Moreover, the Company also re-affirmed its commitment to excellence in 3D spinal innovation. Looking forward, the Company aims to develop innovative products for assisting spine surgeons to offer quality treatments to their patients.
Stock Performance Snapshot
May 17, 2018 - At Thursday's closing bell, K2M Group's stock marginally fell 0.94%, ending the trading session at $21.16.
Volume traded for the day: 153.72 thousand shares.
Stock performance in the last month – up 9.18%; previous three-month period – up 10.21%; past six-month period – up 15.31%; and year-to-date - up 17.56%
After yesterday's close, K2M Group's market cap was at $912.42 million.
The stock is part of the Healthcare sector, categorized under the Medical Appliances & Equipment industry. This sector was up 0.1% at the end of the session.
Active-Investors:
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active-Investors
